Published in Ann N Y Acad Sci on December 01, 2011
Cell and tissue engineering for liver disease. Sci Transl Med (2014) 1.08
Humanized Mouse Model of Ebola Virus Disease Mimics the Immune Responses in Human Disease. J Infect Dis (2015) 0.92
Natural killer cells in hepatitis C: Current progress. World J Gastroenterol (2016) 0.76
Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro. Proc Natl Acad Sci U S A (2006) 3.69
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol (2010) 3.44
Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature (2013) 3.39
A genetically humanized mouse model for hepatitis C virus infection. Nature (2011) 3.15
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol (2009) 2.68
Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe (2009) 2.58
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med (2009) 2.26
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures. Hepatology (2011) 2.13
A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology (2011) 2.06
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci U S A (2012) 2.05
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. Proc Natl Acad Sci U S A (2013) 1.85
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut (2014) 1.70
Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest (2012) 1.52
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro. Proc Natl Acad Sci U S A (2012) 1.48
Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells. Hepatology (2011) 1.42
A mouse model for HIV-1 entry. Proc Natl Acad Sci U S A (2012) 1.23
Animal models for hepatitis C. Curr Top Microbiol Immunol (2013) 1.17
New horizons for studying human hepatotropic infections. J Clin Invest (2010) 1.16
Rapid development of T cell memory. J Immunol (2004) 1.15
Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med (2013) 1.14
Development of CD1d-restricted NKT cells in the mouse thymus. Eur J Immunol (2004) 1.13
C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1. J Virol (2012) 1.05
Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. J Immunol (2007) 1.03
Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitis C virus polyprotein. Virology (2013) 1.01
Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry. J Virol (2010) 1.00
H2-M3-restricted memory T cells: persistence and activation without expansion. J Immunol (2003) 0.98
Insufficient interleukin-12 signalling favours differentiation of human CD4(+) and CD8(+) T cells into GATA-3(+) and GATA-3(+) T-bet(+) subsets in humanized mice. Immunology (2014) 0.95
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology (2013) 0.93
Barriers of hepatitis C virus interspecies transmission. Virology (2013) 0.92
Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice. J Immunol (2013) 0.91
Hepatitis C virus vaccines in the era of new direct-acting antivirals. Expert Rev Gastroenterol Hepatol (2013) 0.91
Development of humanized mouse models to study human malaria parasite infection. Future Microbiol (2012) 0.87
Study of hepatitis C virus entry in genetically humanized mice. Methods (2012) 0.85
Advances and challenges in studying hepatitis C virus in its native environment. Expert Rev Gastroenterol Hepatol (2010) 0.84
Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model. J Virol (2013) 0.84
Modeling malaria in humanized mice: opportunities and challenges. Ann N Y Acad Sci (2015) 0.81
Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. J Virol (2013) 0.78
Exiting from uncharted territory: hepatitis C virus assembles in mouse cell lines. Hepatology (2012) 0.76
Evaluation of combination therapy against hepatitis C virus infection in human liver chimeric mice. J Hepatol (2010) 0.75
Teaching new tricks to an old foe: murinizing hepatitis C virus. Hepatology (2010) 0.75